1Leshner AI. Addiction is a brain disease, and it matters.Science, 1997, 278: 45-47.
2Tortes G, Horowitz JM. Drugs of abuse and brain gene expression. Psychosomatic Medicine, 1999, 61: 630.
3Yamada K, Nabeshima T. Pro-and anti-addictive neurotrophic factors and cytokines in psychostimulant addiction: mini review.Annals of the New York Academy of Sciences, 2004, 1025:198-204.
4Maldonado R, Dauge V, Callebert J, et al. Comparison of selective and complete inhibitors of edkephalin-degrading enzymes on morphine withdrawal syndrome. Eur J Pharmacol,1989, 165: 199-207.
5Biala G, Betancur C, Mansuy IM, et al. The reinforcing effects of chronic d-amphetamine and morphine are impaired in a line of memory-deficient mice overexpressing calcineurin. Eur J Neurosci, 2005, 21: 3089-3096.
6Williams ,IT, Christie MJ, Manzoni O. Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev, 2001,81 : 299-343.
7Ammon S, Mayer P, Riechert U, et al. Microarray analysis of genes expressed in the frontal cortex of rats chronically treated with morphine and after naloxone precipitated withdrawal.Brain Res Mol Brain Res, 2003, 112: 113-125.
8Luscher C, Nicoll RA, Malenka RC, et al. Synaptic plasticity and dynamic modulation of the postsynaptic membrane. Neurosci,2000, 3: 545-550.
9Malenka RC. Synaptic plasticity and AMPA receptor trafficking.Ann N Y Acad Sci, 2003, 1003: 1-11.
10Graham SH, Chen J. Programmed cell death in cerebral ischemia.J Cereb Blood Flow Metab, 2001, 21: 99-109.
